![]()
MIRA INFORM REPORT
|
Report Date : |
04.09.2011 |
IDENTIFICATION DETAILS
|
Name : |
EPS BIO TECHNOLOGY CORP. |
|
|
|
|
Registered Office : |
No.8, R&D Rd. III, Hsinchu Science Park, Hsinchu County 30077 |
|
|
|
|
Country : |
Taiwan |
|
|
|
|
Date of Incorporation : |
22.10.2002 |
|
|
|
|
Com. Reg. No.: |
80064027 |
|
|
|
|
Legal Form : |
Joint Stock Company |
|
|
|
|
Line of Business : |
Manufacturing and sales of medical instrument |
RATING & COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Maximum Credit Limit : |
USD 60,000 |
|
|
|
|
Status : |
Moderate |
|
|
|
|
Payment
Behaviour : |
No Complaints |
|
|
|
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail : infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st, 2011
|
Country Name |
Previous Rating (31.12.2010) |
Current Rating (31.03.2011) |
|
Taiwan |
a2 |
a2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
|
Company Name: |
|
|
Supplied Name: |
EPS Bio Technology Corp |
|
Trading Address: |
No.8, R&D Rd. III, Hsinchu Science
Park, Hsinchu County 30077, Taiwan, R.O.C. |
|
Supplied Address: |
No. 8 R & D RD III Hsinch Science Paark
Hsinchu 30077, Taiwan |
|
Telephone Number: |
+886-3-6686868 |
|
Fax Number: |
+886-3-6686866 |
|
Credit Rating: |
|
|
Credit Opinion: |
|
Registered Name: |
|
|
Registered
Address: |
No.8, R&D Rd. III, Hsinchu Science
Park, Hsinchu County 30077, Taiwan, R.O.C. |
|
Date of
Foundation: |
|
|
Registration
Number: |
|
|
Registry: |
|
|
Registered
Capital: |
NTD 200,000,000
(USD 6,880,000) (As of 2011.09, 1 NTD = 0.0344 USD) |
|
Paid-up Capital: |
NTD 160,000,000
(USD 5,504,000) |
|
Legal
Representatives: |
Lianfu Liu |
|
Legal Form: |
|
|
Principal
Activities: |
|
|
Staff: |
|
|
Listed at Stock Exchange: |
|
|
Date of Last Annual Return: |
Subject was incorporated on 2002-10-22 with registered number 80064027
as Joint Stock Company in Taiwan.
|
Name |
Subscription
Amount |
|
714,300 |
|
| Fenglin Guo |
3,345,400 |
|
649,800 |
|
|
552,000 |
|
|
568,600 |
|
|
688,600 |
|
|
324,800 |
|
|
91,300 |
|
|
812,000 |
Notes: The information above is that of subject’s major
shareholders.
Core Management
|
1 |
|
|
Name |
Lianfu Liu |
|
Position |
Board Chairman |
|
2 |
|
|
Name |
Fenglin Guo |
|
Position |
Vice-President |
|
3 |
|
|
Name |
Yongzhen Lei |
|
Position |
|
|
4 |
|
|
Name |
Yuexin Lai |
|
Position |
|
|
5 |
|
|
Name |
Hongzhe Zhang |
|
Position |
|
|
6 |
|
|
Name |
Boxiong Guo |
|
Position |
|
|
7 |
|
|
Name |
Xiaoqian Guo |
|
Position |
Director |
|
8 |
|
|
Name |
Mouqin Zeng |
|
Position |
|
|
9 |
|
|
Name |
Yifen You |
|
Position |
Auditor |
Personnel Structure
|
Total Employees |
More than 10 Employees |
Offices & Factories
|
|
Headquarters
|
|
Add |
No.8, R&D Rd.
III, Hsinchu Science Park, Hsinchu County 30077, Taiwan, R.O.C. |
l
Subject
produces medical instrument.
l
The subject
produces in Taiwan.
Purchase Information
l
The
components and raw material for production are
mostly purchased from domestic markets.
l
The
subject is mainly engaged in sales of medical instrument.
l
The
subject sells products around the
world.
Import and export right:
|
Import
right |
Yes |
|
Export
right |
Yes |
Purchase
Domestic
Purchase (Taiwan and Mainland, China)
|
Payment
Terms |
Proportion |
|
|
Raw material |
COD,
etc |
100% |
Foreign
Purchase
Sales
Domestic
Markets (Taiwan)
|
Sales
Terms |
Proportion |
|
|
CBD,
etc |
100% |
Export
|
Sales
Terms |
Proportion |
|
|
Medical
instrument |
CBD,
etc |
100% |
|
Year |
Sales |
|
2010 |
About
USD 6,000,000 |
Notes: The information is from introduction.
|
Name |
Taiwan
Bank |
Mortgage
No chattel mortgage
record of subject has been found within the recent 3 months.
Lawsuit
Up to date of reporting, no existing or
latent litigation of the subject has been found.
|
Name |
Ms. Zhang |
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.45.90 |
|
UK Pound |
1 |
Rs.74.31 |
|
Euro |
1 |
Rs.65.41 |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
---- |
NB |
New Business |
---- |
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.